Condensed Statements Of Operations (USD $) Share data in Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012
Condensed Statements Of Operations [Abstract]
SALES	$ 4,082,000	$ 4,735,000	$ 12,405,000	$ 12,530,000
COST OF GOODS SOLD	2,056,000	2,334,000	6,127,000	6,425,000
Gross profit	2,026,000	2,401,000	6,278,000	6,105,000
COSTS AND EXPENSES
Sales and marketing	1,915,000	1,875,000	5,639,000	4,914,000
General and administrative	711,000	797,000	2,094,000	2,573,000
Research and development	538,000	543,000	1,756,000	1,612,000
Change in value of acquisition consideration			(369,000)
Gain on demutualization	(321,000)		(321,000)
Medical device tax	41,000		41,000
Amortization of identifiable intangible assets	26,000	26,000	78,000	65,000
Total costs and expenses	2,910,000	3,241,000	8,918,000	9,164,000
OPERATING LOSS	(884,000)	(840,000)	(2,640,000)	(3,059,000)
INTEREST EXPENSE	(98,000)	(102,000)	(348,000)	(371,000)
FOREIGN CURRENCY EXCHANGE GAIN/(LOSS)	(6,000)	1,000	(9,000)	(3,000)
LOSS BEFORE INCOME TAXES	(988,000)	(941,000)	(2,997,000)	(3,433,000)
INCOME TAX EXPENSE	17,000	27,000	48,000	38,000
NET LOSS	$ (1,005,000)	$ (968,000)	$ (3,045,000)	$ (3,471,000)
NET LOSS PER COMMON SHARE - BASIC	$ (0.05)	$ (0.07)	$ (0.15)	$ (0.24)
NET LOSS PER COMMON SHARE - DILUTED	$ (0.05)	$ (0.07)	$ (0.15)	$ (0.24)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC	20,902	14,778	20,637	14,723
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED	20,902	14,778	20,637	14,723